Table 4.
Treatment characteristics
| First episode (n = 121) | Multiple episode (n = 279) | Total (n = 400) | p-levela | |
|---|---|---|---|---|
| Duration of hospitalization (days) | 53.7 (39.1) | 53.4 (47.0) | 53.5 (44.7) | T = 0.048, p = 0.962 |
| Medicationb | ||||
| First generation antipsychotics | 69.4% (n = 84) | 63.8% (n = 178) | 65.5% (n = 262) | χ2 = 1.181, p = 0.277 |
| Second generation antipsychotics | 46.3% (n = 56) | 52.7% (n = 147) | 50.8% (n = 203) | χ2 = 1.386, p = 0.239 |
| Antidepressants | 11.6% (n = 14) | 23.3% (n = 65) | 19.8% (n = 79) | χ2 = 7.323, p = 0.007 |
| Tranquilizers | 57.9% (n = 70) | 50.9% (n = 142) | 53.0% (n = 212) | χ2 = 1.639, p = 0.200 |
| Mood stabilizers | 5.8% (n = 7) | 14.3% (n = 40) | 11.8% (n = 47) | χ2 = 5.952, p = 0.015 |
Values are presented as means (±standard deviation)
a First episode patients were compared with multiple episode patients
b Multiple entries are possible. The duration of application of these drugs during the whole inpatient treatment period is not mentioned in this presentation